Dietary supplement maker Cili Minerals has agreed to stop manufacturing and selling untested products that promised to treat serious conditions including heart disease, multiple sclerosis, and cancer. The agreement, penned by the Justice Department and the U.S. Attorney in Lafayette, Louisiana, also requires Cili Minerals to recall and destroy all products it made and distributed since June 1, 2014.
Lafayette, Louisiana-based Cili Minerals is owned by Anton S. Botha, and operated under names including Pick and Pay Inc., and Pick and Pay Hyper Inc. Its products were sold under various names including ProLith, Germanium and CilZinCo.
The company’s products were labeled and promoted as treatments for cancer, cardiovascular disease, osteoporosis, depression, epilepsy, arthritis, multiple sclerosis, and other conditions. Because of these claims, the Food and Drug Administration (FDA) said the products were considered unapproved drugs under the law. Since the company had never sought FDA approval for the products, their safety and efficacy could not be guaranteed. Thus, the federal government moved to get the company’s products off the market so they could no longer pose a risk to public safety.
Cili Minerals cannot sell its dietary supplements until it meets several conditions highlighted in the agreement, such as hiring independent experts to inspect the facility and provide a plan that details the corrective actions they’ve taken to prevent such violations from occurring again.